^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Anaplastic Astrocytoma
    Regimen:
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    ASCO.org
    Excerpt:
    ...while no benefit has been demonstrated for adjuvant PCV chemotherapy (procarbazine, lomustine [CCNU], vincristine) in anaplastic astrocytoma…
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    ESMO.org
    Excerpt:
    ...while no benefit has been demonstrated for adjuvant PCV chemotherapy (procarbazine, lomustine [CCNU], vincristine) in anaplastic astrocytoma…